{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:01:44Z","timestamp":1794373304976,"version":"4.9.0"},"reference-count":82,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003185","name":"Fraunhofer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005687","name":"Goethe University Frankfurt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jmsacl.2021.11.001","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T12:57:06Z","timestamp":1636549026000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Endocannabinoids as potential biomarkers: It\u2018s all about pre-analytics"],"prefix":"10.21627","volume":"22","author":[{"given":"Daniel","family":"Kratz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"issue":"26","key":"10.1016\/j.jmsacl.2021.11.001_b0005","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.jchromb.2009.01.008","article-title":"Lipidomic analysis of endocannabinoid metabolism in biological samples","volume":"877","author":"Astarita","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"6284","key":"10.1016\/j.jmsacl.2021.11.001_b0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/npp.2017.130","article-title":"Circulating endocannabinoids: from whence do they come and where are they going?","volume":"43","author":"Hillard","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.jmsacl.2021.11.001_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2826.2008.01676.x","article-title":"Endogenous cannabinoids: structure and metabolism","volume":"20","author":"Bisogno","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0030","first-page":"706","article-title":"Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective","volume":"2011","author":"Zoerner","year":"1811","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0035","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.D094680","article-title":"Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds and their phospholipid precursors in human plasma by UHPLC-MS\/MS","author":"Roehrig","year":"2019","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.jmsacl.2021.11.001_b0040","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00216-010-4103-z","article-title":"Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry","volume":"398","author":"Lam","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"issue":"26","key":"10.1016\/j.jmsacl.2021.11.001_b0045","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.jchromb.2009.04.016","article-title":"Targeted stable-isotope dilution GC-MS\/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma","volume":"877","author":"Zoerner","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040870","article-title":"Urine endocannabinoids as novel non-invasive biomarkers for bladder cancer at early stage","volume":"12","author":"Vago","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jmsacl.2021.11.001_b0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmet.2017.03.005","article-title":"Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women","volume":"6","author":"Fanelli","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fncel.2017.00039","article-title":"The ratio of 2-AG to its isomer 1-AG as an intrinsic fine tuning mechanism of CB1 receptor activation","volume":"11","author":"D\u00f3cs","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"1-2","key":"10.1016\/j.jmsacl.2021.11.001_b0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jns.2009.07.021","article-title":"Plasma endocannabinoid levels in multiple sclerosis","volume":"287","author":"Jean-Gilles","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-019-0256-6","article-title":"Lower circulating endocannabinoid levels in children with autism spectrum disorder","volume":"10","author":"Aran","year":"2019","journal-title":"Mol. Autism"},{"issue":"8","key":"10.1016\/j.jmsacl.2021.11.001_b0075","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0080","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41598-019-38865-4","article-title":"Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer","volume":"9","author":"Grill","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000235870","article-title":"Enhanced anandamide plasma levels in patients with complex regional pain syndrome following traumatic injury: a preliminary report","volume":"43","author":"Kaufmann","year":"2009","journal-title":"Eur. Surg. Res."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/metabo7040055","article-title":"Parameters of the endocannabinoid system as novel biomarkers in sepsis and septic shock","volume":"7","author":"Lafreniere","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0095","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"1","key":"10.1016\/j.jmsacl.2021.11.001_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drudis.2016.08.005","article-title":"Targeting the endocannabinoid system: future therapeutic strategies","volume":"22","author":"Aizpurua-Olaizola","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plefa.2018.11.016","article-title":"The endocannabinoid system: Overview of an emerging multi-faceted therapeutic target","volume":"140","author":"Chanda","year":"2019","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"4","key":"10.1016\/j.jmsacl.2021.11.001_b0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/bjp.bp.108.053843","article-title":"Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis","volume":"194","author":"Koethe","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.jmsacl.2021.11.001_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","article-title":"Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use","volume":"94","author":"Leweke","year":"2007","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.jmsacl.2021.11.001_b0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ab.2008.08.040","article-title":"A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices","volume":"384","author":"Marczylo","year":"2009","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.jmsacl.2021.11.001_b0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ab.2009.08.005","article-title":"Simultaneous quantitative analysis of N-acylethanolamides in clinical samples","volume":"395","author":"Ozalp","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2014.03.019","article-title":"Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices","volume":"958","author":"Ottria","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091302","article-title":"Quantitative lipidomic analysis of osteosarcoma cell-derived products by UHPLC-MS\/MS","volume":"10","author":"Casati","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchromb.2011.06.025","article-title":"Simultaneous UPLC-MS\/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG\/1AG isomerization and degradation by toluene solvent extraction","volume":"883\u2013884","author":"Zoerner","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.talanta.2019.06.004","article-title":"Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma - LC-MS\/MS method validation and pre-analytical characteristics","volume":"204","author":"Gurke","year":"2019","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.jmsacl.2021.11.001_b0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1194\/jlr.M021378","article-title":"Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC\/MS\/MS","volume":"53","author":"Fanelli","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0155","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1515\/CCLM.2006.065","article-title":"Release of anandamide from blood cells","volume":"44","author":"Vogeser","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.jmsacl.2021.11.001_b0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/can.2017.0019","article-title":"Identification of a widespread palmitoylethanolamide contamination in standard laboratory glassware","volume":"2","author":"Angelini","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0165","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120593","article-title":"Implementation of lipidomics in clinical routine: Can fluoride\/citrate blood sampling tubes improve preanalytical stability?","volume":"209","author":"Hahnefeld","year":"2020","journal-title":"Talanta"},{"issue":"6","key":"10.1016\/j.jmsacl.2021.11.001_b0175","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1300695","article-title":"Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2009.02137.x","article-title":"Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis","volume":"30","author":"Caraceni","year":"2010","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.jmsacl.2021.11.001_b0185","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ijo.2011.165","article-title":"Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity","volume":"36","author":"Gatta-Cherifi","year":"2012","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0190","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-09-0643","article-title":"Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects","volume":"161","author":"Di Marzo","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"10.1016\/j.jmsacl.2021.11.001_b0195","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db06-0812","article-title":"Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity","volume":"55","author":"Bluher","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008792","article-title":"Biomarkers of endocannabinoid system activation in severe obesity","volume":"5","author":"Sipe","year":"2010","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.jmsacl.2021.11.001_b0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10286-009-0026-1","article-title":"Circulating endocannabinoid concentrations during orthostatic stress","volume":"19","author":"Schroeder","year":"2009","journal-title":"Clin. Auton. Res."},{"issue":"17","key":"10.1016\/j.jmsacl.2021.11.001_b0210","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1007\/s00216-015-8559-8","article-title":"Quantitative profiling of endocannabinoids in lipoproteins by LC-MS\/MS","volume":"407","author":"Bilgin","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"5","key":"10.1016\/j.jmsacl.2021.11.001_b0215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00406-013-0470-8","article-title":"Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders","volume":"264","author":"Schaefer","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.jmsacl.2021.11.001_b0220","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the peripheral endocannabinoid system in human obesity","volume":"54","author":"Engeli","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jchromb.2014.11.001","article-title":"A quantitiative LC-MS\/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma","volume":"976\u2013977","author":"Gachet","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"14-15","key":"10.1016\/j.jmsacl.2021.11.001_b0230","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jchromb.2009.04.010","article-title":"Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry","volume":"877","author":"Balvers","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.jmsacl.2021.11.001_b0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.jmsacl.2021.11.001_b0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ab.2006.11.027","article-title":"Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry","volume":"361","author":"Schreiber","year":"2007","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.jmsacl.2021.11.001_b0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ab.2012.11.008","article-title":"Liquid chromatography-tandem mass spectrometry analysis of free and esterified fatty acid N-acyl ethanolamines in plasma and blood cells","volume":"434","author":"Balvers","year":"2013","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.jmsacl.2021.11.001_b0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.plefa.2012.09.001","article-title":"Quantitative analysis of multiple fatty acid ethanolamides using ultra-performance liquid chromatography-tandem mass spectrometry","volume":"87","author":"Lin","year":"2012","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4439","article-title":"Surrogate analyte-based quantification of main endocannabinoids in whole blood using liquid chromatography-tandem mass spectrometry","volume":"33","author":"Dong","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpba.2015.03.017","article-title":"Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS\/MS: Application in tumor-bearing mice","volume":"111","author":"Gong","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0265","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.talanta.2018.04.033","article-title":"Study of sample preparation for determination of endocannabinoids and analogous compounds in human serum by LC-MS\/MS in MRM mode","volume":"185","author":"Luque-C\u00f3rdoba","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchromb.2014.03.017","article-title":"Analysis of eicosanoids by LC-MS\/MS and GC-MS\/MS: a historical retrospect and a discussion","volume":"964","author":"Tsikas","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"11","key":"10.1016\/j.jmsacl.2021.11.001_b0275","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2116\/analsci.26.1199","article-title":"Reducing acyl migration during purification of 2-arachidonoylglycerol from biological samples before gas chromatography mass spectrometry analysis","volume":"26","author":"Higuchi","year":"2010","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0280","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1515\/CCLM.2007.197","article-title":"Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples","volume":"45","author":"Vogeser","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0285","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1194\/jlr.D043794","article-title":"Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs","volume":"55","author":"Pastor","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1-2","key":"10.1016\/j.jmsacl.2021.11.001_b0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-3084(02)00068-3","article-title":"Chemical stability of 2-arachidonylglycerol under biological conditions","volume":"119","author":"Rouzer","year":"2002","journal-title":"Chem. Phys. Lipids"},{"issue":"3","key":"10.1016\/j.jmsacl.2021.11.001_b0295","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0300","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-2275(20)32414-7","article-title":"Base- and acid-catalyzed interconversions of O-acyl- and N-acyl-ethanolamines: a cautionary note for lipid analyses","volume":"41","author":"Markey","year":"2000","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.jmsacl.2021.11.001_b0305","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","article-title":"Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men","volume":"31","author":"C\u00f4t\u00e9","year":"2007","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"09","key":"10.1016\/j.jmsacl.2021.11.001_b0310","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-0030-1253344","article-title":"Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea\u2013specific role of oleoylethanolamide","volume":"118","author":"Jumpertz","year":"2010","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"20","key":"10.1016\/j.jmsacl.2021.11.001_b0315","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jchromb.2010.04.024","article-title":"Validation and application of an LC-MS\/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma","volume":"878","author":"Jian","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0320","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00790.x","article-title":"Endocannabinoid signalling: has it got rhythm?","volume":"160","author":"Vaughn","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0325","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2014-3455","article-title":"Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol","volume":"100","author":"Hanlon","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.aca.2020.11.019","article-title":"Plasma and serum oxylipin, endocannabinoid, bile acid, steroid, fatty acid and nonsteroidal anti-inflammatory drug quantification in a 96-well plate format","volume":"1143","author":"Pedersen","year":"2021","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jmsacl.2021.11.001_b0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/tmrv.2002.29404","article-title":"Red blood cell hemolysis during processing","volume":"16","author":"Sowemimo-Coker","year":"2002","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0340","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/elps.201700086","article-title":"A review of blood sample handling and pre-processing for metabolomics studies","volume":"38","author":"Hernandes","year":"2017","journal-title":"Electrophoresis"},{"issue":"3","key":"10.1016\/j.jmsacl.2021.11.001_b0345","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1021\/ac102806p","article-title":"Characterization of differences between blood sample matrices in untargeted metabolomics","volume":"83","author":"Denery","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0350","article-title":"Differences between human plasma and serum metabolite profiles","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jmsacl.2021.11.001_b0355","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/10409238.2015.1050550","article-title":"How it all starts: Initiation of the clotting cascade","volume":"50","author":"Smith","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jmsacl.2021.11.001_b0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/icb.1961.25","article-title":"The effect of colloidal silica on blood coagulation","volume":"39","author":"Margolis","year":"1961","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"issue":"2","key":"10.1016\/j.jmsacl.2021.11.001_b0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00109-010-0691-5","article-title":"Platelet receptor signaling in thrombus formation","volume":"89","author":"Stegner","year":"2011","journal-title":"J. Mol. Med."},{"issue":"17","key":"10.1016\/j.jmsacl.2021.11.001_b0370","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00018-015-1924-0","article-title":"Downstream effects of endocannabinoid on blood cells: implications for health and disease","volume":"72","author":"Gasperi","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0375","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1432-1327.2001.01942.x","article-title":"Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor","volume":"268","author":"Maccarrone","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0380","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1538-7836.2008.03093.x","article-title":"The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1\/CB2 receptors","volume":"6","author":"Baldassarri","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.jmsacl.2021.11.001_b0385","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1096\/fj.01-0181com","article-title":"Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells","volume":"15","author":"Berdyshev","year":"2001","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.jmsacl.2021.11.001_b0390","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0021-9258(18)74839-4","article-title":"A study of the estimation of sodium in blood serum","volume":"113","author":"Ball","year":"1936","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jmsacl.2021.11.001_b0395","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1046\/j.1523-1755.1998.00086.x","article-title":"Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a)","volume":"54","author":"Kronenberg","year":"1998","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.jmsacl.2021.11.001_b0400","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/09537100903121813","article-title":"Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase","volume":"20","author":"Gkini","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.jmsacl.2021.11.001_b0405","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.bjp.0705468","article-title":"Cellular accumulation of anandamide: consensus and controversy","volume":"140","author":"Hillard","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jmsacl.2021.11.001_b0410","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11306-018-1450-9","article-title":"Impact of post-collection freezing delay on the reliability of serum metabolomics in samples reflecting the California mid-term pregnancy biobank","volume":"14","author":"La Frano","year":"2018","journal-title":"Metabolomics"}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X21000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X21000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:25Z","timestamp":1767770545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X21000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":82,"alternative-id":["S2667145X21000262"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2021.11.001","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocannabinoids as potential biomarkers: It\u2018s all about pre-analytics","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2021.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}